Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE™) model
James Mclaughlin
◽
Gabriel Sosne
◽
George Ousler
2021 ◽
Vol Volume 15
◽
pp. 813-816
Hiroshi Toshida
◽
Toshinari Funaki
◽
Koichi Ono
◽
Nobuhito Tabuchi
◽
Sota Watanabe
◽
...
2017 ◽
Vol Volume 11
◽
pp. 1871-1879
◽
Hiroshi Toshida
◽
Toshinari Funaki
◽
Koichi Ono
◽
Nobuhito Tabuchi
◽
Sota Watanabe
◽
...
2021 ◽
Vol 37
(1)
◽
pp. 4-11
Jeongah Shin
◽
Chang Rae Rho
◽
Joon Young Hyon
◽
Tae-Young Chung
◽
Kyung Chul Yoon
◽
...
2016 ◽
Vol 81
(S 01)
◽
pp. S1-S381
A Koshak
◽
L Wei
◽
E Koshak
◽
S Wali
◽
O Alamoudi
◽
...
1990 ◽
Vol 52
(3)
◽
pp. 586-595
◽
Giuseppe Lombardi
◽
Gian Luca De Salvo
◽
Alba Ariela Brandes
◽
Marica Eoli
◽
Roberta Rudà
◽
...
Dawn Matthews
◽
Aaron Ritter
◽
Ronald G. Thomas
◽
Randolph D. Andrews
◽
Ana S. Lukic
◽
...
Close
Export Citation Format
Close
Share Document
Close